![John Markels](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 5 205 $ in data 30/06/2026
John H.
Markels is an Independent Director at Sangamo Therapeutics, Inc. since 2020.
He is a Director at Arcturus Therapeutics, Inc. and Arcturus Therapeutics Ltd. He has been an Independent Director at Arcturus Therapeutics Holdings, Inc. since 2022.
He is an Independent Director at Vaxcyte, Inc. starting in 2026.
Formerly, Dr. Markels was President-Global Vaccines at Merck & Co., Inc. from 2019 to 2022.
Education includes a doctorate from the University of California, Berkeley and an undergraduate degree from the University of Delaware.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 12/06/2025 | 96.384 ( 0,02% ) | 5 205 $ | 30/06/2026 | |
| 05/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 11/02/2020 |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Direttore/Membro del Consiglio | 08/12/2022 |
| VAXCYTE, INC. | Direttore/Membro del Consiglio | 16/07/2026 |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Direttore/Membro del Consiglio | - |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01/03/2022 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
 University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxcyte, Inc.
 Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Arcturus Therapeutics Holdings, Inc.
 Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
